← Back to Search

PHAT Life: Preventing HIV/AIDS Among Teens--YR Arm for HIV/AIDS (PHATLife Trial)

N/A

Waitlist Available

Led By Geri DONENBERG, PhD

Research Sponsored by University of Illinois at Chicago

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

a) male or female gender; b) remanded to a probation program; c) 13-17 years old; d) adolescent is fluent in English; e) are not wards of the Department of Child and Family Services (DCFS); and f) they have not already received the PHAT Life intervention.

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 2 years

Awards & highlights

PHATLife Trial Summary

This trial will compare the effectiveness of two different groups in teaching life skills to 350 offenders ages 13-17. 100 facilitators will be recruited to deliver the intervention and participate in the research.

Eligible Conditions

HIV/AIDS

PHATLife Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

PHATLife Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in HIV/STI Risk Behaviors at 6 months

Secondary outcome measures

Biological Measure of C. Trachomatis Acquisition

Biological Measure of N. Gonorrhoeae Acquisition

Biological Measure of T. Vaginalis Acquisition

+10 more

PHATLife Trial Design

2Treatment groups

Experimental Treatment

Group I: Youth Representative (YR) FacilitatorExperimental Treatment1 Intervention

The PHAT Life: Preventing HIV/AIDS Among Teens--YR Arm intervention is delivered by young adults who were formally in the juvenile justice system. Dosage is 8 2-hour sessions delivered over two weeks.

Group II: Probation Staff (PS) FacilitatorExperimental Treatment1 Intervention

The PHAT Life: Preventing HIV/AIDS Among Teens--PS Arm intervention is delivered by Probation Staff working at the intervention site. Dosage is 8 2-hour sessions delivered over two weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

PHAT Life: Preventing HIV/AIDS Among Teens--YR Arm

2017

N/A

~220

PHAT Life: Preventing HIV/AIDS Among Teens--PS Arm

2017

N/A

~220

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor

607 Previous Clinical Trials

1,559,138 Total Patients Enrolled

National Institute on Minority Health and Health Disparities (NIMHD)NIH

380 Previous Clinical Trials

1,215,436 Total Patients Enrolled

Geri DONENBERG, PhDPrincipal InvestigatorUniversity of Illinois at Chicago

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do individuals who have surpassed their fortieth birthdays qualify for this trial?

"For this clinical trial, adolescents aged between 13 and 17 are eligible for enrollment."

Answered by AI

Are there any specific qualifications necessary to join this clinical experimentation?

"This research initiative is currently recruiting 300 participants aged 13-17 who have HIV infections. Eligibility requires the adolescent to be male or female, remanded to a probation program and fluent in English; they must not also be wards of the Department of Child and Family Services (DCFS) nor have received PHAT Life intervention before."

Answered by AI

Is enrollment for this clinical trial still available?

"As detailed on clinicaltrials.gov, this experiment is no longer accepting participants as it was last updated in February of 2022. Despite the lack of availability for enrollment at present, there are 514 other trials that are actively looking to recruit patients."

Answered by AI